Search

Displaying results 9991 - 10000 of 10000 in total
  1. Drug

    TP-3654

    go.drugbank.com/drugs/DB18109
    Investigational

    Categories: Amino Acids, Peptides, and Proteins, Hormones, Hormone Substitutes, and Hormone Antagonists
  2. Drug

    Epoetin beta

    go.drugbank.com/drugs/DB19434
    Investigational

    Categories: Amino Acids, Peptides, and Proteins, Intercellular Signaling Peptides and Proteins
  3. Drug

    Omoconazole

    go.drugbank.com/drugs/DB13684
    Experimental

    Categories: Imidazole and Triazole Derivatives, Genito Urinary System and Sex Hormones
  4. Drug

    Etilevodopa

    go.drugbank.com/drugs/DB06535
    Experimental

    Categories: Dopa and Dopa Derivatives, Amino Acids, Peptides, and Proteins
  5. Drug

    ALT-801

    go.drugbank.com/drugs/DB15386
    Investigational

    ALT-801 is under investigation in clinical trial NCT01478074 (ALT-801-activated Natural Killer Cells After FLAG Induction for Acute Myeloid Leukemia).

    Categories: Amino Acids, Peptides, and Proteins, Intercellular Signaling Peptides and Proteins
  6. Drug

    Glycocyamine

    go.drugbank.com/drugs/DB02751
    Experimental

    Synonyms: N-amidinoglycine, N-(aminoiminomethyl)glycineCategories: Indicators and Reagents, Amino Acids, Peptides, and Proteins
  7. Drug

    GTX-758

    go.drugbank.com/drugs/DB14969
    Investigational

    GTX-758 is under investigation in clinical trial NCT01420861 (GTx-758 on Serum Prostate-specific Antigen (PSA) in Men With Castrate Resistant Prostate Cancer).

  8. Drug

    MOR-22

    go.drugbank.com/drugs/DB17790
    Experimental

    MOR-22, a Natural human lymphoblastoid interferon-alpha, is currently being investigated to treat papillomavirus warts in the oral cavity of HIV-positive patients.

  9. Drug

    Ecnoglutide

    go.drugbank.com/drugs/DB19019
    Investigational

    Ecnoglutide is under investigation in clinical trial NCT05813795 (A Phase 3 Study to Evaluate the Efficacy of XW003 in Adults With Overweight or Obesity).

  10. Drug

    Nelonicline

    go.drugbank.com/drugs/DB19040
    Investigational

    Nelonicline is under investigation in clinical trial NCT01678755 (A Phase 2 Study to Evaluate ABT-126 for the Treatment of Cognitive Deficits in Schizophrenia).